Fiche publication
Date publication
septembre 2026
Journal
Bipolar disorders
Auteurs
Membres identifiés du Cancéropôle Est :
Pr HAFFEN Emmanuel
Tous les auteurs :
Yocum AK, Alda M, Aouizerate B, Aubin V, Bellivier F, Belzeaux R, Berk M, Biernacka JM, Budde M, Burdick KE, Chang YH, Coombes BJ, Courtet P, Dalkner N, Diaz-Byrd C, Dubertret C, Etain B, Fico G, Fullerton JM, Godin O, Gordon-Smith K, Haffen E, Januel D, Keramatian K, Leboyer M, Lefrere A, Llorca PM, Majd M, Mitchell PB, Mwangi B, Olie E, Overs BJ, Petite J, Polosan M, Rey R, Roberts G, Roux P, Samalin L, Schwan R, Serretti A, Soares JC, Sperry SH, Strawbridge R, Stross T, Vieta E, Walter M, Williams LJ, Wu MJ, Yatham LN, Young AH, Yrondi A, Zunta-Soares GB, Frye MA, McInnis MG, Singh B
Lien Pubmed
Résumé
To investigate pharmacological treatment patterns in individuals with bipolar disorder (BD) with and without comorbid substance use disorder (SUD) and anxiety disorder (AX), we leveraged the Global Bipolar Cohort to analyze cross-regional practices across North America, Europe, and the Pacific.
Mots clés
anxiety disorders, bipolar disorder, comorbidity, global, psychopharmacology, substance use disorders
Référence
Bipolar Disord. 2026 09;28(6):e70167
